Effect of the leukotriene receptor antagonists FPL 55712, LY 163443, and MK-571 on the elimination of cysteinyl leukotrienes in the rat.

Por Denzlinger, C., Grimberg, M., Kapp, A., Haberl, C., Wilmanns, W.
Publicado em 1991

Tumour associated antigens in diagnosis of serous effusions.

Por Mezger, J, Permanetter, W, Gerbes, A L, Wilmanns, W, Lamerz, R
Publicado em 1988

Prognosis after salvage treatment for unselected male patients with germ cell tumours.

Por Gerl, A., Clemm, C., Schmeller, N., Hartenstein, R., Lamerz, R., Wilmanns, W.
Publicado em 1995

Advances in the management of metastatic non-seminomatous germ cell tumours during the cisplatin era: a single-institution experience.

Por Gerl, A., Clemm, C., Schmeller, N., Hartenstein, R., Lamerz, R., Wilmanns, W.
Publicado em 1996

Release of prostaglandin D2 by murine mast cells: importance of metabolite formation for antiproliferative activity.

Por Haberl, C, Hültner, L, Flügel, A, Falk, M, Geuenich, S, Wilmanns, W, Denzlinger, C
Publicado em 1998

Sequential resection of residual abdominal and thoracic masses after chemotherapy for metastatic non-seminomatous germ cell tumours.

Por Gerl, A., Clemm, C., Schmeller, N., Dienemann, H., Weiss, M., Kriegmair, M., Löhrs, U., Wilmanns, W.
Publicado em 1994

Paraneoplastic chronic intestinal pseudoobstruction as a rare complication of bronchial carcinoid.

Por Gerl, A, Storck, M, Schalhorn, A, Müller-Höcker, J, Jauch, K W, Schildberg, F W, Wilmanns, W
Publicado em 1992

Serum pharmacology of amphotericin B applied in lipid emulsions.

Por Heinemann, V, Kähny, B, Jehn, U, Mühlbayer, D, Debus, A, Wachholz, K, Bosse, D, Kolb, H J, Wilmanns, W
Publicado em 1997

Pharmacokinetics of liposomal amphotericin B (Ambisome) in critically ill patients.

Por Heinemann, V, Bosse, D, Jehn, U, Kähny, B, Wachholz, K, Debus, A, Scholz, P, Kolb, H J, Wilmanns, W
Publicado em 1997